AstraZeneca-Oxford Shot Backed by WHO for All Adults

The video discusses the distribution of vaccines through the COVAX facility, highlighting its global reach and the logistical advantages of storing the vaccine at ordinary refrigerated temperatures. Despite potential reductions in efficacy against severe disease, the vaccine is recommended for use, even in countries with circulating variants. The prioritization roadmap identifies people over 65 as a priority group, and the vaccine is recommended for individuals 18 and older without an upper age limit.

What factors were considered in the safety assessment of the vaccine?

Why is the vaccine recommended for people over 65 years of age?